科學+家 混合肌醇 | SCIENTIST HOME Mixed Inositol 150g

In stock
Product Details
品牌 Brand: Scientist Home


症狀包含 :月經不規律或無月經、月經量過多、多毛症、粉刺、盆腔疼痛、難以受孕、黑棘皮症等等

科學+家 混合肌醇


  • 周期不适(1,2,3)
  • 頭髮稀疏(4)
  • 唇毛(5)
  • 体毛(5)
  • 粉刺(6)
  • 睡眠障碍(7)


  • 本品為營養補充品,不能代替藥物
  • 如有不適反應,建議停止服用
  • 妊娠期和哺乳期婦女慎用
  • 如不瞭解問題原因或問題持續,請儘快諮詢醫生

主要成份: 肌醇、D-手性肌醇

飲用方法 每日二次,每次一平量匙,餐后以250毫升温水冲开后饮用



包 裝150克/粉劑

原 產 地中國香港

Polycystic ovary syndrome (PCOS)
Polycystic ovary syndrome (PCOS) affects 5%-10% of women in reproductive age, and it is the most common cause of infertility due to ovarian dysfunction and menstrual irregularity. Several studies have reported that insulin resistance is common in PCOS women, regardless of the body mass index. The importance of insulin resistance in PCOS is also suggested by the fact that insulin-sensitizing compounds have been proposed as putative treatments to solve the hyperinsulinemia-induced dysfunction of ovarian response to endogenous gonadotropins. Rescuing the ovarian response to endogenous gonadotropins reduces hyperandrogenemia and re-establishes menstrual cyclicity and ovulation, increasing the chance of a spontaneous pregnancy. Among the insulin-sensitizing compounds, there is myo-inosiol (MYO). Previous studies have demonstrated that MYO is capable of restoring spontaneous ovarian activity, and consequently fertility, in most patients with PCOS. With the present review, we aim to provide an overview on the clinical outcomes of the MYO use as a treatment to improve ovarian function and metabolic and hormonal parameters in women with PCOS.

Symptoms include: Irregular or irregular menstruation, Menorrhagia, Hirsutism, Acne, Pelvic Pain, Difficult to conceive, Acanthosis nigricans

Scientist Home Mixed Inositol
Possible supplements supporting::
  • Periodic discomfort(1,2,3)
  • Thinning hair(4)

  • Labial hair(5)
  • Body hair(5)
  • Acne(6)
  • Sleep disturbances(7)

Consumption: 1 to 2 teaspoons each time after meal, to be taken once or twice a day. May dissolve the powder in water, juice or tea.


  • This product is a nutritional supplement and cannot replace medicine.
  • If there is any discomfort, it is recommended to stop taking it.
  • Use with caution for pregnant and lactating women.
  • If you do not understand the cause of the problem or the problem persists, please consult your doctor as soon as possible.

Main ingredients: Inositol, d-chiral inositol

Note: Some women may have Allergy to inositol, mild diarrhea without abdominal pain is normal. (don't go out within 1 hour after drinking)

Storage method: Please store in a cool and dry place.

Origin: Hong Kong, China

Ingredient: Inositol, D-chiro-inositol

Packaging: 150g per bottle.


1. Gerli S, Papaleo E, Ferrari A, et al. Randomized, double-blind, placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS. Eur Rev Med Pharmacol Sci. 2007;11:347-354

2. Costantino D, Minozzi G, Minozzi E, Guaraldi C. Metabolic and hormonal effects of myo-inositol in women with polycystic ovary
syndrome: a double-blind trial. Eur Rev. Med Pharmacol Sci. 2009;13(2):105-110.

3. Raffone E, Rizzo P, Benedetto V. Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women. Gynecol Endocrinol. 2010;26(4):275-280.

4. Ablon Glynis, MD, FAAD. A Double-blind, Placebo-controlled Study Evaluating the Efficacy of an Oral Supplement in Women with Self-perceived Thinning Hair. J Clin Aesthet Dermatol. v.5(11); 2012 Nov. PMC3509882

5. M Minozzi,1 G D’Andrea,2 V Unfer2,31First Institute of Obstetrics and Gynecology, University La Sapienza; 2A.G.UN.CO. Obstetrics and Gynecology Centre, Rome, Italy. Treatment of hirsutism with myo-inositol: a prospective clinical study. RBMOnline - Vol 17 No 4. 2008 579-582 Reproductive BioMedicine Online; www.rbmonline.com/Article/3299 on web 20 August 2008.

6. Michele Pezza, Valentina Carlomagno, Ambulatorio di Dermatologia Casa di Cura Villa Maria Passo di Mirabella Eclano (AV), Italy. Inositol in women suffering from acne and PCOS: a randomized study . DOI: 10.15761/GOD.1000203

7. Renae C Fernandez,1,2,3 Vivienne M. Moore,1,3,4 Emer M Van Ryswyk,5 Tamara J Varcoe,1,2 Raymond J Rodgers,1,2 Wendy. A March,1,3 Lisa J Moran,1,6 Jodie C Avery,1,2 R Doug McEvoy,5,7 and Michael J. Davies1,2. Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies. Journal
List Nat Sci Sleep v.10; 2018 PMC5799701

This product is not registered under the Pharmacy and Poisons Ordinance or the Chinese Medicine Ordinance. Any claim made for it has not been subject to evaluation for such registration. This product is not intended to diagnose, treat or prevent any disease.

Save this product for later